Sort
326,823 grants matching “clinical trial”
Next Generation HSC Gene Therapy for HIV Control and Eradication
$2,514,507Paula M Cannon · University Of Southern California · U19 · FY2017 · HL
Next Generation HSC Gene Therapy for HIV Control and Eradication
$2,514,507Paula M Cannon · University Of Southern California · U19 · FY2016 · HL
Immunologic And Virologic Approaches To HIV-1 Therapeutics
$2,513,865Richard Davey · Niaid Extramural Activities · Z01 · FY2007 · AI
African American Eye Disease Study
$2,513,732Rohit Varma · University Of Southern California · U10 · FY2014 · EY
UT Southwestern Liver Cancer SPORE
$2,513,300Amit Singal · Ut Southwestern Medical Center · P50 · FY2025 · CA
Excess cardiovascular inflammation in TB and HIV: EXFIN-TB
$2,513,201Gregory P. Bisson · University Of Pennsylvania · R01 · FY2025 · HL
Emory WIHS CRS - Longitudinal Cohort
$2,512,902Ighovwerha Ofotokun · Emory University · U01 · FY2017 · AI
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC
$2,512,822Yvonne W Wu · University Of California, San Francisco · U01 · FY2017 · NS
MRI Based Presymptomatic Prediction of ASD
$2,512,610John R Pruett · Washington University · R01 · FY2022 · MH
Mobilizing Community Systems to Engage Families in Early ASD Detection & Services
$2,512,390Amy M Wetherby · Florida State University · R01 · FY2016 · MH
Neurological Emergencies Treatment Trials Network: Clinical Coordinating Center
$2,512,150William G Barsan · University Of Michigan At Ann Arbor · U01 · FY2008 · NS
Cancer Center Support Grant
$2,512,026William L. Carroll · New York University School Of Medicine · P30 · FY2011 · CA
Cancer Center Support Grant
$2,512,026William L. Carroll · New York University School Of Medicine · P30 · FY2012 · CA
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
$2,511,684Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
A Severe Hemophilia A Intergenerational Cohort Research Program for the Study of Factor VIII Immunogenicity
$2,511,468Jill Marie Johnsen · University Of Washington · UG3 · FY2023 · HL
Molecular Targeting of Developmental Cancers in Children
$2,511,105Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
TDP-43 aggregation inhibitors for the treatment of ALS
$2,510,981Glenn Larsen · Aquinnah Pharmaceuticals, Inc. · R44 · FY2019 · NS
DEVELOP, QUALIFY IMMUNOLOGICAL ASSAYS, AND PROVIDE CLINICAL SAMPLE TESTING FOR AAV-BASED GENE THERAPY CLINICAL CANDIDATES
$2,510,508Lynn Briscoe · Leidos Biomedical Research, Inc. · N01 · FY2025 · CA
Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA^3CT )
$2,510,320Michael L. Terrin · University Of Maryland Baltimore · R01 · FY2013 · AG
Malaria Vaccines: TBV Antigens as Conjugates with Alternate Carriers
$2,510,151Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
The Pediatric Brain Tumor Consortium (PBTC)
$2,510,122James M Boyett · St. Jude Children'S Research Hospital · U01 · FY2008 · CA
Protection of Ischemic Myocardium
$2,509,828Roberto Bolli · University Of Louisville · P01 · FY2014 · HL
Mechanisms of Frustration and the Pathophysiology of Severe Irritability in Youth
$2,509,796Ellen Leibenluft · National Institute Of Mental Health · ZIA · FY2022 · MH
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and sensor-augmented pump therapy in outpatient settings
$2,509,367Remi Rabasa-Lhoret · Clinical Research Institute Of Montreal · DP3 · FY2015 · DK
Fred Hutchinson Cancer Research Center Lung SPORE
$2,509,264A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2020 · CA